Renal replacement therapies in pediatric intensive care patients: Experiences of one center in Turkey

BACKGROUND: Despite constant improvements in caring for critically ill neonates and infants with congenital cardiac disease, sepsis, bone marrow and solid organ transplantation, acute renal failure (ARF) is an important problem in these children. ARF, severe fluid overload and inborn errors of metabolism are some of the indications for acute dialysis in infants and children. METHODS: The authors had retrospectively evaluated the medical records of Pediatric Intensive Care Unit, Ankara University School of Medicine, Ankara, Turkey patients who had required acute renal replacement therapy between the dates of January 2002 to February 2005. RESULTS: Medical records of 332 patients were reviewed. Acute renal replacement therapy was performed in 21 patients (6.3%; mean age, 9.6 +/- 7.4 years). Dialysis modalities were peritoneal dialysis in 15 patients (71.4%; mean age, 3.9 +/- 5.6 years) and hemodialysis in six patients (28.6%; mean age, 12.1 +/- 3.2 years). A total of 90% of patients had severe systemic disease leading to ARF. A total of 95% of patients had multiple organ dysfunction syndrome. The most common cause of ARF was refractory shock. At the beginning of renal replacement therapy, 10 patients were anuric, nine patients had volume overload, seven patients had decompensated metabolic acidosis and nine patients had hypotension. The average dialysis period was 4.7 +/- 6.4 days. Mortality rate was 66.7%. Eight patients recovered from ARF and chronic renal failure had developed in one patient. CONCLUSION: In the Pediatric Intensive Care Unit, ARF is frequently seen together with multiple organ dysfunction syndrome and the mortality rate is high. Both peritoneal dialysis and hemodialysis are important renal replacement treatment modalities in patients with ARF. The age and hemodynamic status of the patients are important when choosing treatment modality; generally peritoneal dialysis is preferred in infants and toddler, while hemodialysis is preferred in older children.     

原发性高血压合并脑梗塞患者血管紧张素Ⅱ-1型受体基因多态性的研究

目的 探讨血管紧张素Ⅱ－1型受体（angiotensin Ⅱ type 1 receptor,AT1R)基因A1166／C多态性与原发性高血压及合并脑梗塞的关系。方法 应用聚合酶链反应－限制性片段长度多态性方法检测70名健康人、72例原发性高血压无合并症患者及70例原发性高血压合并脑梗塞患者的AT1R基因型；生化技术测定血脂水平。结果 原发性高血压无合并症组及合并脑梗塞组的C等位基因频率分别为11．1％和10．7％，均显著高于正常对照组的3．6％（P＜0．05）；而两者之间的C等位基因频率差异无显著性（P＞0．05）；牟发性高血压患者血浆脂蛋白a水平与AT1R基因正相关。结论 提示AT1R基因可能是原发性高血压的重要遗传因素，但与高血压病患者是否易患脑梗塞无关。     

多囊卵巢综合征患者复方醋酸环丙孕酮治疗前后激素和糖代谢变化的临床观察

为观察达英-35治疗多囊卵巢综合征(PCOS)在明显降低黄体生成素(LH)及睾酮(T)水平,改善患者内分泌状况的同时,是否改善其胰岛素抵抗(IR),35例PCOS患者服用复方醋酸环丙孕酮(达英-35)治疗3个周期,观察用药前后临床特征、血清激素水平、空腹血糖、空腹胰岛素(FIN)的变化.结果显示,治疗后34例PCOS患者月经恢复,多毛及痤疮评分下降(P<0.01),双侧卵巢体积明显缩小(P<0.01).血清LH、FSH、T水平和LH/FSH明显下降(P<0.01).FIN水平明显下降(P<0.01),IR也有相应降低(P<0.01),空腹血糖(FBG)和胰岛素敏感性指数(ISI)无明显改变(P>0.05).达英-35有很强的抗雄作用,明显改善了PCOS患者的内分泌状况和临床症状.     

血管内超声对冠状动脉临界病变的临床应用

目的应用血管内超声(IVUS)对冠状动脉造影(CAG)提示冠状动脉临界病变的患者检查,评价IVUS在冠状动脉临界病变诊断及治疗中的应用价值。方法选择经CAG诊断为冠状动脉存在临界狭窄的78例患者,其中男性56例,女性22例;年龄34～71岁,平均年龄55.4岁。行IVUS检查和CAG,对照分析两种检查结果。结果CAG检测发现偏心性斑块31处,向心性斑块82处;而行IVUS检测发现偏心性斑块56处,向心性斑块57处。IVUS清楚显示软斑块54处,硬斑块23处,混合性斑块36例,其中探查血栓1处,溃疡2处;而CAG不能显示管腔形态及斑块特点。病变最窄处血管面积狭窄率IVUS所测值明显高于CAG,分别为68%±21%、58%±19%(P<0.05),两者比较差异具有统计学意义。结论对于CAG显示的临界狭窄病变,IVUS能更准确地判定管腔形态、病变性质及狭窄程度,对冠心病特别是有冠心病症状的患者的诊断及临床介入治疗有重要意义.     

力学载荷对破骨细胞凋亡的影响及其调节机制

破骨细胞是参与骨代谢的基本功能细胞之一.破骨细胞在骨重建过程中主要承担旧骨组织的破坏和吸收,因此,破骨细胞凋亡的微小变化都可能会改变骨重建的进程.调节破骨细胞凋亡的因素有很多,如雌激素、二磷酸盐等生物化学因素,但力学载荷对于破骨细胞生物学活性影响的研究相对较少.综述了力学载荷对破骨细胞生物学活性的影响以及细胞凋亡与破骨细胞凋亡的调节.     

经胸超声心动图无创性评价先天性主动脉瓣病变

目的 评价经胸超声心动图在诊断先天性主动脉瓣病变中的应用价值.方法 临床确诊的先天性主动脉瓣病变患者43例,其中男性25例,女性18例;年龄4～46岁,平均年龄234岁.纯合子家族性高胆固醇血症(HoFH)患者7例,主动脉瓣二叶畸形(BAV)患者35例,罕见的主动脉瓣下移畸形1例.回顾分析经胸超声心动图检查结果,并与彩...     

高血压丘脑出血破入脑室的临床治疗体会

目的：探讨高血压丘脑出血破入脑室的治疗方法。方法：回顾分析本院高血压丘脑出血破入脑室30例患者的临床资料,15例行双侧脑室外引流术,6例行血肿穿刺引流＋脑室外引流,5例行开颅血肿清除,4例意识清醒。结果：生活自理18例,中残6例,重残3例,死亡3例。结论：高血压丘脑出血破入脑室者应急诊行脑室外引流。     

经胸与经食管超声心动图在先天性心脏病介入治疗中的应用

导管室介入封堵及外科小切口介入封堵都已经被广泛地应用于临床,封堵成功的关键在于经胸与经食管超声心动图在术前对病例精确的筛选、术中监测及术后即刻评价。文章结合目前国内外文献及临床病例,对经胸与经食管超声心动图在房间隔缺损、室间隔缺损和动脉导管未闭3种常见先天性心脏病介入治疗中的应用进行综述,为临床提供更加准确的超声影像学诊断依据。     

Ad-GFP修饰MSCs静脉移植在严重烫伤延迟复苏大鼠体内的定向迁移

目的:观察携带目的基因的大鼠骨髓间充质干细胞(mesenchymal stem cells ,MSCs) 静脉移植在严重烫伤延迟复苏损伤体内的分布.方法:分离培养MSCs,用Ad-GFP转染MSCs,25只Wistar大鼠随机分为延迟复苏组(A组,10只)、即时复苏组(B组,10只)、假伤组(C组,5只).A、B两组大鼠背部造成Ⅲ度30%烫伤,制备A组为延迟复苏模型,B组为即时复苏模型,同时制备C组为假伤模型,经股静脉移植转染Ad-GFP 48 h后的MSCs.24 h,7 d后取小肠、肝脏、肾脏、烫伤皮肤创缘等组织,快速冰冻切片,荧光显微镜下观察在体内的分布.结果:MSCs 体外分离培养扩增5代,细胞数可达(1～2)×1011个,具有多态性和贴壁生长特性,MOI=100时,Ad-GFP转染MSCs效率可达86.4%.经股静脉移植24 h,在延迟复苏组烫伤皮肤组织创缘,小肠黏膜广泛可见绿色荧光,而在肝、肺等器官少见,即时复苏组荧光以烫伤皮肤创缘分布为主,小肠黏膜较少,假伤组中绿色荧光分布以肝脏为主.延迟复苏组小肠荧光强度明显强于即时复苏组和假伤组(P《0.05),而延迟和即时复苏组皮肤创缘荧光强度又强于假伤组(P《0.05).结论:导入目的基因可能不会改变MSCs归巢特性,并将为后续启动基因治疗烧伤延迟复苏后的损伤研究提供参考.